(Q40984822)

25 September 2017

Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells (English)

1 reference

25 September 2017

1 reference

2

1 reference

25 September 2017

Festuccia C

1

1 reference

25 September 2017

Guerra F

3

1 reference

25 September 2017

Violini S

4

1 reference

25 September 2017

Muzi P

5

1 reference

25 September 2017

Pavan A

6

1 reference

25 September 2017

Bologna M

7

1 reference

25 September 2017

1 August 1998

1 reference

Clinical & Experimental Metastasis

25 September 2017

1 reference

25 September 2017

16

1 reference

25 September 2017

513-528

1 reference

25 September 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1006590217724

25 September 2017

0 references

cites work

Tumor-associated urokinase-type plasminogen activator: biological and clinical significance

1 reference

12 December 2020

Growth factors in the regulation of pericellular proteolysis: a review

1 reference

12 December 2020

Prevention of metastasis by inhibition of the urokinase receptor

1 reference

12 December 2020

The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type

1 reference

12 December 2020

Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme

1 reference

12 December 2020

Enzyme-linked immunosorbent assay for human urokinase-type plasminogen activator and its proenzyme using a combination of monoclonal and polyclonal antibodies

1 reference

12 December 2020

Microplate immunocapture assay for plasminogen activators and their specific inhibitors

1 reference

12 December 2020

The urokinase receptor: involvement in cell surface proteolysis and cancer invasion

1 reference

12 December 2020

Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants

1 reference

12 December 2020

Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts

1 reference

12 December 2020

Increased matrix metalloproteinase-9 secretion in short-term tissue cultures of prostatic tumor cells.

1 reference

12 December 2020

Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness

1 reference

12 December 2020

Plasminogen activator activities in short-term tissue cultures of benign prostatic hyperplasia and prostatic carcinoma

1 reference

12 December 2020

Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas

1 reference

12 December 2020

Inhibition of urokinase-type plasminogen activator by antibodies: the effect on dissemination of a human tumor in the nude mouse

1 reference

12 December 2020

Cell-associated plasminogen activation: regulation and physiological functions

1 reference

12 December 2020

Autocrine saturation of pro-urokinase receptors on human A431 cells.

1 reference

12 December 2020

Plasminogen activator dependent pathways in the dissemination of human tumor cells in the chick embryo

1 reference

12 December 2020

Bombesin stimulates growth of human prostatic cancer cells in vitro

1 reference

12 December 2020

Binding and activation of plasminogen on the platelet surface

1 reference

12 December 2020

Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase-type plasminogen activator and cathepsin B

1 reference

12 December 2020

Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo.

1 reference

12 December 2020

Modulation of metastatic potential by cell surface urokinase of murine melanoma cells

1 reference

12 December 2020

Effect of epidermal growth factor on prostate cancer cell line PC3 growth and invasion

1 reference

12 December 2020

Inhibition of cancer cell urokinase plasminogen activator by its specific inhibitor PAI-2 and subsequent effects on extracellular matrix degradation

1 reference

12 December 2020

Inhibition of the soluble and the tumor cell receptor-bound plasmin by urinary trypsin inhibitor and subsequent effects on tumor cell invasion and metastasis

1 reference

12 December 2020

Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia

1 reference

12 December 2020

In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin

1 reference

12 December 2020

Differential expression of uPA in an aggressive (DU 145) and a nonaggressive (1013L) human prostate cancer xenograft

1 reference

12 December 2020

Plasminogen activator and metalloprotease activities of Du-145, PC-3, and 1-LN-PC-3-1A human prostate tumors grown in nude mice: correlation with tumor invasive behavior.

1 reference

12 December 2020

The urokinase inhibitor p-aminobenzamidine inhibits growth of a human prostate tumor in SCID mice

1 reference

12 December 2020

Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells

1 reference

12 December 2020

Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors

1 reference

12 December 2020

Inhibition of cell surface receptor-bound plasmin by alpha 2-antiplasmin and alpha 2-macroglobulin

1 reference

12 December 2020

An inhibitor of plasminogen activation from human placenta. Purification and characterization

1 reference

12 December 2020

Involvement of Urokinase and its Receptor in the Invasiveness of Human Prostatic Carcinoma Cell Lines

1 reference

12 December 2020

Plasminogen activators, tissue degradation, and cancer

1 reference

12 December 2020

A modified invasion-3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide assay for quantitating tumor cell invasion.

1 reference

12 December 2020

Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma

1 reference

12 December 2020

Diversity and modulation of plasminogen activator activity in human prostate carcinoma cell lines

1 reference

12 December 2020

Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol

1 reference

12 December 2020

Directed plasminogen activation at the surface of normal and malignant cells

1 reference

12 December 2020

Linkage of extracellular plasminogen activator to the fibroblast cytoskeleton: colocalization of cell surface urokinase with vinculin

1 reference

12 December 2020

Cell membrane receptors for urokinase plasminogen activator are increased in malignant ovarian tumours

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1006590217724

1 reference

Dimensions Publication ID

25 September 2017

0 references

1 reference